Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Plasma LH is commonly elevated in women with the polycystic ovary syndrome (PCOS), but the underlying mechanisms are uncertain. We tested the hypothesis that the elevated LH in part reflects a reduced sensitivity of the hypothalamic GnRH pulse generator to suppression by estradiol (E2) and progesterone (P). In an initial protocol, normal controls (beginning on cycle days 8-10) and women with PCOS were given E2 transdermally and P by vaginal suppository (three times daily), to achieve plasma concentrations similar to those in the midluteal phase of an ovulatory cycle, for 21 days. Blood was obtained at 10-min intervals for 12 h before and on days 5, 10, 20, and 28 (7 days after E2 and P were discontinued). LH pulse amplitude and LH pulse frequency were suppressed in both PCOS and normal controls, but LH pulse frequency fell more rapidly in controls and was lower by day 10 (P < 0.05). Based on this time course a dose-response study was performed, in which E2 in constant dosage and varying concentrations of P were administered for 7 days. Pulsatile LH release was appraised on days 1 and 7. The frequency of LH pulse secretion was reduced in controls and was lower than that in patients with PCOS on day 7 (P < 0.0001). Plasma P concentrations of 13-15 ng/mL suppressed LH pulse frequency to a similar degree in PCOS and controls. In contrast, lower concentrations (P < 10 ng/mL) were more effective in suppressing GnRH/LH pulse frequency in controls (by > 45% of basal) than in PCOS (< 40%; P < 0.01). The data indicate that E2 and P can inhibit the activity of the hypothalamic GnRH pulse generator in women with PCOS. However, higher plasma concentrations of P were required to reduce GnRH/LH pulse frequency in PCOS compared to controls, suggesting an insensitivity of the GnRH pulse generator to suppression by E2 and P. These results suggest that an abnormality in the regulation of hypothalamic GnRH secretion is present in PCOS and may be a factor in the etiology of the disorder in adolescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When developing female embryos are exposed to relatively high levels of testosterone—such as in females who develop PCOS—many aspects of HPG activity are affected. Hypothalamic sensitivity to steroid‐induced negative feedback is reduced, resulting in an increased frequency and amplitude of gonadotropin‐releasing hormone (GnRH) and luteinizing hormone (LH) pulses with corresponding increases in LH”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Pastor et al., 1998
Citations
Cites
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861 · cited 1×
“Data are presented as the mean 6 se. The number of LH pulses and pulse amplitude were measured by the computer algorithm Cluster ( 32 ), using parameters of threshold change corresponding to a t statistic of 2.45 for both the peak upstroke and the peak downstroke.”
MethodInfluentialNestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
WILDT, L., HÄUSLER, A., MARSHALL, G., HUTCHISON, J. S., PLANT, T. M., BELCHETZ, P. E., & KNOBIL, E. (1981) · Endocrinology · doi:10.1210/endo-109-2-376 · Cited by 684
BARBIERI, R. L., MAKRIS, A., RANDALL, R. W., DANIELS, G., KISTNER, R. W., & RYAN, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 630 · cited 1×
“The fall in plasma LH after reduction of insulin in some studies may reflect the coexistent reduction in plasma androgen levels due to reduced enhancement of ovarian androgen secretion by insulin ( 53 , 54).”
BackgroundCharacterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Taylor, A. E., McCourt, B., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4105 · Cited by 494
FILICORI, M., SANTORO, N., MERRIAM, G. R., & CROWLEY, W. F. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1136 · Cited by 489
Cited by
Items 201–300 of 314
Polycystic Ovarian Syndrome and Female Infertility
Naqvi, S. M. A. S., Bhattarai, J. B., Li, H., & Wang, X. W. (2019) · Yangtze Medicine · doi:10.4236/ym.2020.41002 · Cited by 9
“In hyperandrogenemic girls certain to develop PCOS, increase in ovarian steroids may not be adequate to suppress the GnRH pulse generator, leading to a persistently rapid LH pulse frequency, reduced FSH generation, and insufficient follicular development [8] [9].”
BackgroundBeyond the ovary: rewiring our perspective on polycystic ovary syndrome
Campbell, R. E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00963-3 · Cited by 9
Neuroendocrinology of Reproduction
McCartney, C. R., & Marshall, J. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00001-9 · Cited by 13
Self-citationBernard, D. J., & Brûlé, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00007-9 · Cited by 10
Periodograms and pulse detection methods for pulsatile hormone data
Grambsch, P. M., Meller, W. H., & Grambsch, P. V. (2002) · Statistics in Medicine · doi:10.1002/sim.1051 · Cited by 9
Tinano, F. R., Machado, I. F. R., Latronico, A. C., & Gomes, L. G. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1681-24.2024 · Cited by 9
Hobeika, E. M., Armouti, M., Kala, H. S., & Stocco, C. O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00025-0 · Cited by 11
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome
Mathyk, B. A., Cetin, E. C., & Yıldız, B. O. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000772 · Cited by 8
Current insights into gonadotropic pituitary function in the polycystic ovary syndrome
Feuser, C. S., Barbosa, J. S., da Silva, E. B., & de Medeiros, S. F. (2014) · Asian Pacific Journal of Reproduction · doi:10.1016/s2305-0500(14)60004-x · Cited by 11
Shirin, S., Murray, F., Goshtasebi, A., Kalidasan, D., & Prior, J. C. (2021) · Medicina · doi:10.3390/medicina57101024 · Cited by 9
“A number of causes for PCOS are postulated, including androgen exposure in utero, genetic risks, and inflammation [10]; however, increasing evidence suggests that PCOS is characterized by a central dysregulation of the hypothalamic–pituitary–ovarian axis with rapid pulsing of gonadotrophin releasing hormone [11,12].”
BackgroundSheep as a model for neuroendocrinology research
Foradori, C. D., & Mackay, L. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.01.001 · Cited by 10
Microglia: sculptors of the polycystic ovary syndrome (PCOS)-like brain?
Sati, A., Desroziers, E., & Campbell, R. E. (2023) · Reproduction · doi:10.1530/rep-22-0343 · Cited by 7
“Reproduction (2023) 166 R51–R61 with reproductively fit controls (Pastor et al. 1998).”
BackgroundAltered multihormone synchrony in obese patients with polycystic ovary syndrome
Roelfsema, F., Kok, P., Veldhuis, J. D., & Pijl, H. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.011 · Cited by 7
Ouladsahebmadarek, E., & Khaki, A. (2014) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2014.27 · Cited by 6
Barbu, R. M. (2021) · FARMACIA · doi:10.31925/farmacia.2021.1.11 · Cited by 6
“Another significant effect of oestrogen on brain tissue is the stimulation of cerebral vascularization, possibly by mechanisms similar to those that occur in the coronary arteries (by coupling with endothelial receptors and stimulating the release of nitric oxide, which causes vasodilation) [29].”
BackgroundHyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Barnes, R. B., Ehrmann, D. A., & Rosenfield, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00132-5 · Cited by 7
Tfayli, H. M., Arslanian, S. A., & Witchel, S. F. (2025) · Reproduction · doi:10.1530/rep-25-0115 · Cited by 7
Insight into the pathogensis of polycystic ovarian syndrome
Jung, Y. W., Lee, G. H., Han, Y. J., & Cha, D. H. (2020) · Journal of genetic medicine · doi:10.5734/jgm.2020.17.1.1 · Cited by 5
“to steroid hormone can be restored with AR antagonist [37,78].”
BackgroundNawaito, S. A., Esmael, M., Souchkova, O., Cardinal, T., Bernas, G., Bergeron, K., Gayda, F., Bergeron, F., Bouchard, M., Zhou, X., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202401718rr · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 6
The pathogenic role of androgen excess in PCOS
Pignatelli, D., Pereira, S. S., & Kandaraki, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00017-1 · Cited by 4
Abbott, D. H., Levine, J. E., Dumesic, P. A., Padmanabhan, V., & Dumesic, D. A. (2025) · Reproduction · doi:10.1530/rep-25-0120 · Cited by 5
Yaralí, H., Bozdağ, G., Polat, M., Yaralı, İ., & Humaidan, P. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.11.004 · Cited by 4
“Another contributing factor to the pregnancy could be increased luteal LH levels and decreased sensitivity of the GnRH pulse generator to inhibit ovarian steroids, previously reported in patients with polycystic ovary syndrome (Pastor et al., 1998).”
BackgroundPolycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Chen, Z., Tan, J., Wang, H., Zheng, B., Liu, J., Hao, G., Guo, Z., Sun, Z., & Yu, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.813188 · Cited by 6
Effects of lupeol and flutamide on experimentally-induced polycystic ovary syndrome in mice.
Rezaei-Golmisheh, A., Sadrkhanlou, R., Ahmadi, A., & Malekinejad, H. (2024) · PubMed Central · doi:10.22038/ijbms.2024.77602.16783 · Cited by 6
Pathogenesis and Management of Adiposity and Insulin Resistance in Polycystic Ovary Syndrome (PCOS)
Barber, T. M., Joharatnam, J., & Franks, S. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_36 · Cited by 4
Kim, S. H., Solorzano, C. M. B., & McCartney, C. R. (2018) · Physiological Reports · doi:10.14814/phy2.13680 · Cited by 4
“2006), and such antagonism may relate both to the degree of suppression – as previously described (Pastor et al. 1998; Eagleson et al. 2000) – and the rapidity of suppression.”
BackgroundInfluentialNatural Approaches for Treating Polycystic Ovary Syndrome
Meletis, C. D., & Zabriskie, N. (2006) · Alternative and Complementary Therapies · doi:10.1089/act.2006.12.157 · Cited by 4
Advances in the treatment of polycystic ovary syndrome
Moghetti, P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1631 · Cited by 4
The Menstrual Cycle and Disorders of Ovulation
Marshall, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00129-3 · Cited by 4
Self-citationKisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders
Pierret, A. C. S., Patel, A., Daniels, E., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2025) · Andrology · doi:10.1111/andr.13843 · Cited by 3
Animal models of polycystic ovary syndrome
Kulkarni, S., Dahake, D., Gupta, K., Rathod, K., Aswar, U. M., & Thareja, S. (2025) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2025.2551005 · Cited by 3
“Impaired leptin signaling further inhibits folliculogenesis, impairs embryo implantation, and reduces endometrial receptivity, leading to PCO morphology development, accompanied by obesity (Pastor et al. 1998; Lebrethon et al. 2000).”
Incidence of Canine Tick Vectors and Molecular Detection of Haemoparasites in Vectors and Hosts
Jena, A., Baidya, S., Pandit, S., Jas, R., Mandal, S. C., Brahma, A., & Mishra, S. (2021) · Indian Journal of Animal Research · doi:10.18805/ijar.b-4229 · Cited by 3
Kim, S. H., Lundgren, J. A., Patrie, J. T., Solorzano, C. M. B., & McCartney, C. R. (2022) · Physiological Reports · doi:10.14814/phy2.15233 · Cited by 3
“In addition, the GnRH pulse generator is relatively resistant to progesterone negative feedback in women with polycystic ovary syndrome (PCOS) (Daniels & Berga, 1997; Pastor et al., 1998), and the time course of progesterone- related LH pulse frequency lowering in PCOS is similarly unclear.”
BackgroundInfluentialKulle, A. E., Caliebe, A., Lamprecht, T., Reinehr, T., Ŝimić-Schleicher, G., Schulz, E., Kleber, M., Rothermel, J., Heger, S., Hiort, O., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae046 · Cited by 4
The Hypothalamic–Pituitary Axis in PCOS
Gill, S., & Hall, J. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_6 · Cited by 5
New routes in the polycystic ovary syndrome labyrinth: A way out?
Moghetti, P., & Castello, R. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350793 · Cited by 3
Forslund, M., Melin, J. M., Joham, A. E., Piltonen, T., Rees, A., & Teede, H. J. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70156 · Cited by 2
“…PMOS is increased pulse frequency of GnRH from the hypothalamus, accompanied by diminished sex–steroid negative feedback at the level of the hypothalamus, result-596 ing in preferential secretion of luteinizing hormone (LH) over follicle-stimulating hormone (FSH) from the pituitary gland [31–33].”
Ovulation induction in anovulatory PCOS women
DIAMANTI, M., & Marca, A. L. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.24.05633-1 · Cited by 4
d-chiro-Inositol enhances effects of hypothalamic toxin gold-thioglucose
Isoda, F., Shiry, L., Abergel, J. R., Allan, G., & Mobbs, C. V. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.008 · Cited by 2
Polyzystisches Ovarsyndrom (PCOS)
Neumann, K., & Griesinger, G. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57636-6_7 · Cited by 3
Hirsutismo: diagnóstico y conducta práctica
Bachelot, A. (2011) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(11)71021-2 · Cited by 2
Firing patterns of gonadotropin-releasing hormone neurons are sculpted by their biologic state
Penix, J., DeFazio, R. A., Dulka, E. A., Schnell, S. D., & Moenter, S. M. (2020) · Royal Society Open Science · doi:10.1098/rsos.201040 · Cited by 2
Glendining, K. A., Prescott, M., Potapov, K., Kip, E., & Campbell, R. E. (2026) · Journal of Neuroendocrinology · doi:10.1111/jne.70181 · Cited by 1
“11 – 13 Impaired negative feedback regulation of GnRH/LH secretion, in particular, is thought to underlie the pathological features of PCOS 5,7,11,12,14,15 which include oligo/an-ovulation, clinical and/or biochemical hyperan-drogenism, and polycystic appearance of the ovaries.”
Kadium, D. A. H., Kaem, G. G., Saeq, Z. M. A., & Safar, Z. A. A. (2016) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v2i5.63 · Cited by 2
Adolesanda Polikistik Over Sendromu
Şahin, L., & Aygün, B. (2013) · Fırat Tıp Dergisi · Cited by 3
Abshire, M. Y., Blank, S. K., Chhabra, S., McCartney, C. R., Eagleson, C. A., & Marshall, J. C. (2011) · Endocrine · doi:10.1007/s12020-011-9563-1 · Cited by 1
“Administration of progesterone (P) decreases GnRH pulse frequency in normal women, but the GnRH pulse generator in women with PCOS is relatively insensitive to P negative feedback [2].”
BackgroundSelf-citationRuman, U. (2015) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2015.02.00064 · Cited by 1
“Women with PCOS have abnormally rapid LH pulses with reduced response to progesterone feedback, which in turn leads to elevations in LH:FSH ratios [16].”
BackgroundThe Brain Phenotype in Polycystic Ovary Syndrome (PCOS): Androgens, Anovulation, and Gender
Berga, S. L. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_1 · Cited by 1
Hirsutismo: diagnóstico y conducta práctica
Bachelot, A. (2017) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(17)86942-7 · Cited by 1
Areloegbe, S. E. J., Atuma, C. L., Oyabambi, A. O., & Olaniyi, K. S. (2023) · Nutrire · doi:10.1186/s41110-023-00205-y · Cited by 2
“More so, elevated testosterone is typically driven by LH pulse frequency [33] which itself is likely a downstream of dysregulated steroidogenesis and sex steroid feedback [61].”
BackgroundGurule, S. C., Sustaita-Monroe, J. F., King, L. N., Landers, R. S. M., Garza, V., West, S. M., Bynum, S., Perry, L., Padmanabhan, V., & Cardoso, R. C. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1436954 · Cited by 1
Estrogen — Progestagen therapy in the management of the polycystic ovary syndrome
Marshall, J. C. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350787 · Cited by 1
Self-citationBoyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Androgene und Insulin in Pathophysiologie und Genetik des PCO-Syndroms
Schüring, A. N., Sonntag, B., & Kiesel, L. (2006) · Gynäkologische Endokrinologie · doi:10.1007/s10304-006-0154-9 · Cited by 1
Gonadotropin secretory dynamics in polycystic ovary syndrome
Baker, E. M., Flora, S. A., Ferguson, J. E., II, & Evans, W. S. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00006 · Cited by 1
Self-citationImpact of polycystic ovary syndrome on methyl group metabolism
Bries, A. E. (2020) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210114-18 · Cited by 1
Marcondes, R. R. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2012.tde-27022013-164003 · Cited by 1
Sánchez, I. O. (2014) · BURJC Digital (King Juan Carlos University)
The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists
Berga, S. L. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350789
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Hypothalamic-Pituitary-Gonadotropic Dysfunction in the Polycystic Ovary Syndrome
Chang, R. J., & Mehta, R. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_17
“Moreover, in a study of women with PCOS that employed the administration of progesterone and estradiol at physiological concentrations equivalent to those found in the midluteal phase of normal women, LH pulse frequency was not diminished compared to the reduced rate found in a group of normal women studied similarly…”
ResultPolycystic ovarian disease in adult and perimenopausal women
(2014) · Healthy Aging Research · doi:10.12715/har.2014.3.8
“Administration of progesterone or OCP results in a greater suppression of mean LH and LH pulse frequency in normal women compared with women with PCOD [53, 54].”
ResultFarzadi, L., Khaki, A., Ghasemzadeh, A., Asl, Z., Ahamadi, S., & Ashteani, H. (2013)
Franks, S., & Joharatnam, J. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_24 · Cited by 1
Solano, M. E. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Pubertal Precursors of the Polycystic Ovarian Syndrome
Marshall, J. C., McCartney, C. R., Blank, S. K., & Okonkwo, Q. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_7
“Women with PCOS require higher concentrations of progesterone to suppress GnRH frequency to the same degree as ovulatory controls ( 40 ).”
BackgroundSelf-citationMarcondes, R. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-13112017-155147
Davoodian, N., Khetvan-Hafshejani, R., Kadivar, A., Mousavi, M. M., Aali, E., Gheami, A., Moghadam, B. B., & Shirian, S. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.3.74
Síndrome dos ovários policísticos e doença hepática gordurosa não alcóolica: o que sabemos?
Pinto, F. H. A. D. M., Nardelli, M. J., Elias, M. L. C., Santos, B. C., Couto, C. A., Rocha, A. L. L., & Faria, L. C. (2019) · Revista Médica de Minas Gerais · doi:10.5935/2238-3182.20190033
Gonadotropins—Regulation of Synthesis and Secretion
Haisenleder, D. J., & Marshall, J. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00117-9
Self-citationBiochemical Pathways and Modeling
DEANGELIS, A., DeAngelis, L. M., Catherino, W. H., & ROLLENE, N. L. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000583
Teixeira, R. P. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-28092021-112205 · Cited by 1
Neuroendocrine Dysfunction in Polycystic Ovary Syndrome
McCartney, C. R., Eagleson, C. A., & Marshall, J. C. (2002) · Informa Healthcare eBooks · doi:10.1201/9780203910948.ch8
Self-citationLeite, J. M., de Araújo, R. H. C., Silva, E. P. G. E., Teixeira, A. V. O., Peres, M. L., Moreira, C. F., & Cruz, J. F. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n3-239
de Souza, I. S. M., Pereira, L. M. D. A., do Nascimento, J. A. A., Peixoto, M. D. S. R. M., Filho, G. B. D. O., do Monte, T. V. S., & Júnior, J. G. D. S. (2022) · doi:10.22533/at.ed.2312204086
COINFECÇÃO FÚNGICA EM PACIENTES COM TUBERCULOSE E/OU HIV
Ewerton, J. N., do Nascimento, N. C. S. V., Machado, K. R. G., dos Santos, J. R. A., Furtado, H. L. A., & Holanda, R. A. (2022) · doi:10.22533/at.ed.2312204083
Oliveira, A. B. D. N., da Silva, L. N., Ostanel, N., Bazon, J. N., Terçariol, C. A. S., & Crisci, A. R. (2022) · doi:10.22533/at.ed.2312204087
A IMPORTÂNCIA DO RASTREAMENTO GENÉTICO NA PREVENÇÃO DO CÂNCER DE MAMA
Gigonzac, T. C. V., Lima, F. S., Esber, G. G. K., Uchoa, E. M. G. S., Souza, T. C. E., Dourado, I. D. S., & Gigonzac, M. A. D. (2022) · doi:10.22533/at.ed.2312204082
Ferreira, M. G., Alves, P. G. V., Röder, D. V. D. D. B., & Menezes, R. D. P. (2022) · doi:10.22533/at.ed.2312204084
A IMPORTÂNCIA DA AMAMENTAÇÃO: UMA REVISÃO DE LITERATURA
de Oliveira, S. S., Madeira, W. M., Amaral, C. A., & Aliança, A. S. D. S. (2022) · doi:10.22533/at.ed.2312204081
POLÍTICAS PÚBLICAS HIV/AIDS E IDOSOS: UMA REVISÃO INTEGRATIVA
Costa, R. E., Pereira, A. B. R., Vilela, J. B. F., Oliveira, R. B. D. A., & Soares, L. R. (2022) · doi:10.22533/at.ed.2312204085
Berg, T. (2018) · Deep Blue (University of Michigan)
Mimouni, N. E. H. (2019) · theses.fr (ABES) · doi:10.70675/6171e11bzeb74z4007zab79z6a74592fdf32
Gavilán, G. R., Culebro, R. L., Vieyra-Valdez, E., Ramírez, D. A., Moreno, J. A. E., Ortega, A. C., Casalá, R. D., & Morales‐Ledesma, L. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100182
Ott, J., Holzer, I., & Goebl, C. S. (2024) · ISGE series · doi:10.1007/978-3-031-55300-4_7
The GnRH pulse generator activity in mouse models of polycystic ovary syndromePreprint
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2024) · eLife · doi:10.7554/elife.97179.1
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa1
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa2
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa0
Jaime, J. (2024) · Deep Blue (University of Michigan) · doi:10.7302/23900
GnRH pulse generator activity in mouse models of polycystic ovary syndromePreprint
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2024) · eLife · doi:10.7554/elife.97179.2 · Cited by 2
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_27
Metadata
- Authors
- Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C.
- Affiliations
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-02
- Volume
- 83
- Issue
- 2
- Pages
- 582-590
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2122612739
- Cited by
- 263
- References
- 54
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 12 · 2020: 14 · 2019: 20 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd016000-18)
- National Center for Research Resources (M01RR000847, M01-RR 00847)
- NIH Clinical Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30 HD28934, R01-HD-16000, P30HD028934)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, gonadotropin-releasing hormone, LH pulse frequency, LH pulse amplitude, estradiol, progesterone, hypothalamic-pituitary-gonadal axis, LH secretion regulation, transdermal estradiol, vaginal progesterone
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Estradiol, Female, Follicle Stimulating Hormone, Humans, Hypothalamus, Kinetics, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Periodicity, Polycystic Ovary Syndrome, Progesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.